Applications of urinary proteomics in biomarker discovery

被引:0
|
作者
Chen Shao
Yan Wang
YouHe Gao
机构
[1] Peking Union Medical College,National Key Laboratory of Medical Molecular Biology, Department of Physiology and Pathophysiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences/School of Basic Medicine
来源
关键词
urine; proteomics; biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
Urine is an important source of biomarkers. This article reviews current advances, major challenges, and future prospects in the field of urinary proteomics. Because the practical clinical problem is to distinguish diseases with similar symptoms, merely comparing samples from patients of a particular disease to those of healthy individuals is inadequate for finding biomarkers with sufficient diagnostic power. In addition, the variation of expression levels of urinary proteins among healthy individuals and individuals under different physiological conditions adds to the difficulty in identifying biomarkers. We propose that establishing the natural variation in urinary protein expression among a healthy population can serve as a reference to help identify protein abundance changes that are caused by disease, not by individual variations or physiological changes. We also discuss that comparing protein expression levels between urine and plasma may reveal the physiological function of the kidney and that may facilitate biomarker discovery. Finally, we propose that establishing a data-sharing platform for data collection and integrating results from all urinary biomarker studies will help promote the development of urinary proteomics.
引用
收藏
页码:409 / 417
页数:8
相关论文
共 50 条
  • [41] Biomarker discovery by monoclonal antibody proteomics
    Guttman, A.
    Karger, B. L.
    Hancock, W. S.
    Takacs, L.
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : S86 - S86
  • [42] Shotgun proteomics for biomarker discovery in tissues
    Liebler, Daniel C.
    CANCER BIOMARKERS, 2008, 4 (03) : 179 - 179
  • [43] Proteomics in biomarker discovery and drug development
    He, QY
    Chiu, JF
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 89 (05) : 868 - 886
  • [44] Proteomics is not only a biomarker discovery tool
    Martins-de-Souza, Daniel
    PROTEOMICS CLINICAL APPLICATIONS, 2009, 3 (10) : 1136 - 1139
  • [45] Artificial intelligence for proteomics and biomarker discovery
    Mann, Matthias
    Kumar, Chanchal
    Zeng, Wen-Feng
    Strauss, Maximilian T.
    CELL SYSTEMS, 2021, 12 (08) : 759 - 770
  • [46] Revisiting biomarker discovery by plasma proteomics
    Geyer, Philipp E.
    Holdt, Lesca M.
    Teupser, Daniel
    Mann, Matthias
    MOLECULAR SYSTEMS BIOLOGY, 2017, 13 (09)
  • [47] Proteomics techniques in protein biomarker discovery
    Mahsa Babaei
    Soheila Kashanian
    HuangTeck Lee
    Frances Harding
    Quantitative Biology, 2024, 12 (01) : 53 - 69
  • [48] Functional proteomics for biomarker and target discovery
    LaBaer, J.
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : S140 - S140
  • [49] Quantitative Proteomics for Cancer Biomarker Discovery
    Liang, Shufang
    Xu, Zhizhong
    Xu, Xuejiao
    Zhao, Xia
    Huang, Canhua
    Wei, Yuquan
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2012, 15 (03) : 221 - 231
  • [50] Prostate tissue proteomics for biomarker discovery
    Liu, BC
    Zheng, YX
    Xu, Y
    Bin, Y
    Lei, JY
    Richie, JP
    JOURNAL OF UROLOGY, 2003, 169 (04): : 53 - 53